A simple X-ray measure linked to survival in lung cancer surgery patients: Study

A new study shows that a simple measurement from routine chest X-rays can help predict survival among patients with lung cancer and breathing disorders. Researchers found that lower diaphragmatic dome height (DDH) before surgery was associated with poorer long-term outcomes and higher respiratory-related deaths. This is the first study to establish DDH as a practical prognostic marker, offering a low-cost, widely accessible way to identify high-risk patients and guide treatment decisions.

Lung cancer remains one of the leading causes of cancer-related deaths worldwide. Although surgery offers the best chance of cure, predicting how patients will recover and survive after surgery is still a major clinical challenge. This is especially true for individuals with obstructive ventilatory disorder (OVD), a condition marked by airflow limitation that reduces breathing efficiency and thereby increases the risk of complications after surgery. Currently, reliable prediction often depends on complex tests or specialized assessments that are not always practical in routine clinical settings.

Now, a new study published online on April 21, 2026, in the International Journal of Clinical Oncology suggests that a simple measurement from routine chest X-rays could help address this limitation. The study was led by Mr. Masaya Noguchi, a physical therapist at Kindai University Hospital, Japan, along with colleagues, Dr. Yuji Higashimoto, Dr. Toshiki Takemoto, and Dr. Yasuhiro Tsutani, from Kindai University. The team aimed to identify a practical and accessible way to assess surgical risk using routinely available clinical data.

At the center of their investigation is diaphragmatic dome height (DDH), a measurement that reflects the position and function of the diaphragm, the primary muscle involved in breathing. A low DDH may reflect diaphragmatic dysfunction, which can compromise breathing efficiency and recovery after surgery. To examine its clinical value, the researchers conducted a retrospective study involving 302 patients with lung cancer and OVD who underwent lobectomy between 2017 and 2024. DDH was measured using chest radiographs taken one month prior to surgery. Patients were then categorized into low and high DDH groups and were followed to assess survival outcomes.

The findings revealed a clear and clinically meaningful pattern. Patients with lower DDH experienced reduced survival rates compared to those with higher DDH. Specifically, the low DDH group showed lower three-year overall survival (70% vs 85%) and disease-specific survival rates. They were also more likely to die from respiratory causes, such as pneumonia or respiratory failure. Importantly, DDH remained an independent prognostic factor even after accounting for other established risk indicators, including tumor stage and pulmonary function. Interestingly, conventional pulmonary function tests, which are commonly used to assess surgical risk, did not show a strong association with survival in this study. In contrast, DDH provided additional prognostic insight, suggesting that it may capture aspects of respiratory function that standard tests do not fully reflect.

“By evaluating DDH using routine chest radiographs, postoperative prognosis can be predicted without the need for additional examinations,” explains Mr. Noguchi. “This enables early and simple identification of high-risk patients and allows clinicians to tailor treatment strategies accordingly.”

The practical implications of these findings are significant. Because chest X-rays are already a standard part of preoperative evaluation, DDH can be assessed without increasing cost, time, or patient burden. This makes it a highly feasible tool for real-world clinical settings, including resource-limited environments. Early identification of high-risk patients could enable targeted interventions, such as intensified preoperative respiratory rehabilitation, optimized perioperative care, and more individualized surgical planning. Over time, this approach may help reduce complications, shorten hospital stays, and improve long-term survival.

Looking ahead, the researchers believe that DDH could become part of routine risk assessment frameworks in lung cancer care. “In the future, incorporating DDH into clinical practice may allow for more efficient and personalized treatment strategies,” says Mr. Noguchi. “It also has the potential to improve long-term outcomes and quality of life for patients.”

While further multicenter studies are needed to validate these findings, this study highlights the untapped potential of simple, widely available tools. By turning a routine chest X-ray into a useful prognostic tool, the research opens a new avenue for improving care in patients undergoing lung cancer surgery.

Reference:

Noguchi, M., Higashimoto, Y., Takemoto, T. et al. Association between preoperative diaphragmatic dome height for overall survival in patients with lung cancer and obstructive ventilatory disorder. Int J Clin Oncol (2026). https://doi.org/10.1007/s10147-026-03022-1